A phase I trial of 100㎎/m2 docetaxel in advanced or recurrent breast cancer patients

Okayama Igakkai Zasshi (Journal of Okayama Medical Association) ◽

10.4044/joma.127.41 ◽

2015 ◽

Vol 127 (1) ◽

pp. 41-45

Author(s):

Taizo Hirata

Keyword(s):

Breast Cancer ◽

Phase I ◽

Cancer Patients ◽

Phase I Trial ◽

Recurrent Breast Cancer ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

Abstract P3-10-07: Phase I trial of eribulin in combination with S-1 for advanced and recurrent breast cancer patients

10.1158/1538-7445.sabcs14-p3-10-07 ◽

2015 ◽

Author(s):

Tsutomu Iwasa ◽

Junji Tsurutani ◽

Satomi Nishida ◽

Yoshifumi Komoike ◽

Kazuhiko Nakagawa

Keyword(s):

Breast Cancer ◽

Phase I ◽

Cancer Patients ◽

Phase I Trial ◽

Recurrent Breast Cancer ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients

Breast Cancer ◽

10.2325/jbcs.13.159 ◽

2006 ◽

Vol 13 (2) ◽

pp. 159-165 ◽

Author(s):

Toshiaki Saeki ◽

Shigemitsu Takashima ◽

Masami Ogita ◽

Toshio Tabei ◽

Isamu Adachi ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Cancer Patients ◽

Combination Chemotherapy ◽

Recurrent Breast Cancer ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

Abstract OT3-01-06: A phase I/IIa study of the whole-cell vaccine BriaVax™ in metastatic or locally recurrent breast cancer patients (NCT00095862)

10.1158/1538-7445.sabcs16-ot3-01-06 ◽

2017 ◽

Author(s):

CL Wiseman ◽

M Lacher

Keyword(s):

Breast Cancer ◽

Phase I ◽

Cancer Patients ◽

Recurrent Breast Cancer ◽

Cell Vaccine ◽

Breast Cancer Patients ◽

Whole Cell Vaccine ◽

Locally Recurrent ◽

Recurrent Breast

Download Full-text

P3-11-03: A Phase I Trial of D-Limonene in Newly Diagnosed Breast Cancer Patients: A Chemoprevention Study.

10.1158/0008-5472.sabcs11-p3-11-03 ◽

2011 ◽

Author(s):

JE Lang ◽

JA Miller ◽

BT Nokes ◽

LG LeBeau ◽

M Delbridge ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Cancer Patients ◽

Phase I Trial ◽

Newly Diagnosed ◽

Breast Cancer Patients

Download Full-text

Abstract CT302: A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic or recurrent breast cancer patients with triple negative disease

10.1158/1538-7445.am2014-ct302 ◽

2014 ◽

Author(s):

Stacy Cowherd ◽

Susan Melin ◽

Steven Akman ◽

John Cole ◽

Julia Lawrence

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Cancer Patients ◽

Phase Ii ◽

Triple Negative ◽

Recurrent Breast Cancer ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

Abstract OT1-01-01: A phase I trial of the safety and immunogenicity of a multiple antigen vaccine (STEMVAC) in HER2 negative advanced stage breast cancer patients

10.1158/1538-7445.sabcs15-ot1-01-01 ◽

2016 ◽

Author(s):

DM Higgins ◽

JS Childs ◽

LG Salazar ◽

ML Disis

Keyword(s):

Breast Cancer ◽

Phase I ◽

Cancer Patients ◽

Phase I Trial ◽

Advanced Stage ◽

Breast Cancer Patients ◽

Multiple Antigen ◽

Antigen Vaccine ◽

Multiple Antigen Vaccine

Download Full-text

Abstract P1-19-03: A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging in patients receiving WBRT with or without sorafenib

10.1158/1538-7445.sabcs18-p1-19-03 ◽

2019 ◽

Author(s):

A Morikawa ◽

K Jhaveri ◽

M Grkovski ◽

K Tang ◽

JL Humm ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase I ◽

Brain Imaging ◽

Cancer Patients ◽

Phase I Trial ◽

Whole Brain Radiotherapy ◽

Breast Cancer Patients ◽

Brain Radiotherapy ◽

Download Full-text

218. T-DM1 therapy for advanced or recurrent breast cancer patients in the late line

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2016.06.151 ◽

2016 ◽

Vol 42 (9) ◽

pp. S126

Author(s):

T. Morimoto ◽

S. Michishita

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Recurrent Breast Cancer ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging to evaluate treatment response after WBRT sorafenib.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps2103 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS2103-TPS2103 ◽

Author(s):

Aki Morikawa ◽

Komal L. Jhaveri ◽

Sujata Patil ◽

Melanie Chen ◽

Edward McDonnell ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase I ◽

Treatment Response ◽

Cancer Patients ◽

Phase I Trial ◽

Whole Brain Radiotherapy ◽

Breast Cancer Patients ◽

Brain Radiotherapy ◽

Download Full-text

Anti-tumor activity of PM1183 (lurbinectedin) in combination with capecitabine in metastatic breast cancer patients: Results from a phase I trial.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.1072 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 1072-1072

Author(s):

Ahmad Awada ◽

Philippe Georges Aftimos ◽

Emiliano Calvo ◽

Valentina Boni ◽

Victor Moreno ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase I ◽

Cancer Patients ◽

Phase I Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Anti Tumor Activity

Download Full-text